Scientists developed a method to produce functional megakaryocytes from human induced pluripotent stem cells-derived CD34+ hematopoietic stem cells under a feeder-free and xeno-free condition and minimized the risk and variation from the animal-derived products in cell cultures.
[Journal of Pharmacology and Experimental Therapeutics]